{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-095687","form_type":"8-K","ticker":"GYRE","cik":"0001124105","company_name":"GYRE THERAPEUTICS, INC.","filed_at":"2024-08-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.229774+00:00","generated_at":"2026-05-31T09:35:40.630044+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Gyre Therapeutics Q2 revenue down 14% to $25.2M, net income up to $4.5M; receives NMPA approval for avatrombopag","bullets":["Q2 revenue $25.2M (-14% YoY) on normalized ETUARY sales; net income $4.5M vs $3.8M YoY.","H1 revenue $52.4M (-3.5% YoY); net income $14.5M vs $8.0M YoY, driven by lower costs.","Received NMPA approval for avatrombopag for CLD thrombocytopenia (July 2024); expanded rare disease portfolio.","IND approved for F230 in PAH; Phase 3 F351 CHB data expected early 2025; U.S. IND for F351 in MASH by end 2024.","Appointed David M. Epstein to Board; cash and investments ~$54M, sufficient for 12+ months."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-095687","json":"https://secwatch.observer/filing/0000950170-24-095687.json","markdown":"https://secwatch.observer/filing/0000950170-24-095687.md","text":"https://secwatch.observer/filing/0000950170-24-095687.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1124105/000095017024095687/0000950170-24-095687-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1124105/000095017024095687/gyre-20240813.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:35:40.630044+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}